ANGELA CHUMLEY: Open Payments
NPI 1508802737 · RINCON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,114 in 67 payments from 18 companies in 2025. Trend: 2023 $460 · 2024 $1,337 · 2025 $1,114
Food & beverage: $1,114
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $269 |
| ABBVIE INC. | 18 | $231 |
| AstraZeneca Pharmaceuticals LP | 6 | $102 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $90 |
| PFIZER INC. | 4 | $78 |
| Exact Sciences Corporation | 4 | $65 |
| Lilly USA, LLC | 2 | $43 |
| Boston Scientific Corporation | 1 | $34 |
| Dexcom, Inc. | 2 | $31 |
| Amgen Inc. | 2 | $28 |
Products named: VRAYLAR, QULIPTA, Ozempic, CAPLYTA, Rybelsus, Wegovy, FARXIGA, The Cologuard Plus Collection Kit.
Industry payments across GA — which companies pay providers there.
